Patients with diabetes have increased circulating levels of inflammatory markers including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and chemokine (C–C motif) ligand 2 (CCL2) [12]. This evidence concerns the gene TNF and diabetes mellitus.